SUBSCRIBE BY RSS rss feed | EMAIL
Natural Solutions Radio header image

Alzheimer

Harvard researchers say they've found new clue to Alzheimer's disease

Canadian Press

06-23-08

WASHINGTON - Researchers have uncovered a new clue to the cause of Alzheimer's disease.

The brains of people with the memory-robbing form of dementia are cluttered with a plaque made up of beta-amyloid, a sticky protein. But there long has been a question whether this is a cause of the disease or a side effect. Also involved are tangles of a protein called tau; some scientists suspect this is the cause.

Topics: 

10 Million Baby Boomers Face Alzheimer's, Report Predicts

By Steven Reinberg

HealthDay Reporter
Tuesday, March 18, 2008; 12:00 AM

TUESDAY, March 18 (HealthDay News) -- An estimated 10 million American baby boomers will develop Alzheimer's disease in their lifetime, placing enormous strains on the U.S. health-care system and the already overburdened network of caregivers, a new report predicts.

Topics: 

The helmet that could turn back the symptoms of Alzheimer's

By DAVID DERBYSHIRE

 An experimental helmet which scientists say could reverse the
 symptoms of Alzheimer's disease within weeks of being used is to be
 tried out on patients.

 The strange-looking headgear - which has to be worn for ten minutes
 every day - bathes the brain with infra-red light and stimulates the
 growth of brain cells.

 Its creators believe it could reverse the symptoms of dementia -
 such as memory loss and anxiety - after only four weeks.

Topics: 

Alzheimer’s: Is it a disease of the Western diet?

15 November 2007

Alzheimer’s and dementia may be a result of the Western diet, new research suggests.  People who eat a diet that’s rich in fish, omega-3 oils, fruits and vegetables are up to 60 per cent less likely to develop Alzheimer’s – whereas people who consume large amounts of omega-6 oils, such as sunflower and grape seed, double their chances of suffering dementia.

Topics: 

Simple blood test could predict Alzheimer's risk

Mon Oct 15, 2007

By Julie Steenhuysen

CHICAGO (Reuters) - Researchers have developed a simple blood test that may be able to predict whether mild lapses of memory could be an early sign of Alzheimer's disease.

In a study published on Sunday in the journal Nature Medicine, an international team of researchers describe 18 cell-signaling, or communication, proteins found in blood that predicted with 90 percent accuracy whether a person would develop Alzheimer's disease.

Topics: 

Alzheimer's Patients Lining Up for Microchip

Aug. 28, 2007

For families of the nearly 5 million Americans currently living with Alzheimer's disease, keeping their loved ones safe is a major concern.

In response to such concerns, a Florida-based company has developed an FDA-approved microchip that can be implanted in an Alzheimer's patient's arm, allowing critical medical details to be accessed instantly.

Up to 200 Alzheimer's patients living near Palm Beach, Fla., will be implanted with the VeriChip for free in the next week.

Topics: 

Alzheimer's Vaccine Combats Tau Protein

Scientists from the New York University Medical Centre have developed an Alzheimer's disease vaccine that combats tau protein in the nervous system of lab mice

According to US scientists, a new vaccine that works by fighting a prominant protein found in Alzheimer's disease may offer hope for a possible cure.

Abnormal tau protein accumulates in the part of a person's brain responsible for memory, however the new vaccine created by scientists at the New York University Medical Centre (NYUMC) prevented the protein from tangling in certain parts of the nervous system in lab mice.

Topics: 

Glaucoma and Alzheimer's May Have Common Origins and Treatment

LONDON, Aug. 6 -- A combination of drugs that target the amyloid-beta pathway

implicated in Alzheimer's disease appear to be highly effective against glaucoma as well, at least in animal models, investigators here reported.

Amyloid-b peptide, found to accumulate in the brains of people with Alzheimer's disease, accelerated the programmed death of retinal ganglion cells in rat models of glaucoma, but its action was prevented by three drugs that inhibit Ab formation and aggregation, wrote M.

Topics: